Malignant pleural effusion as the presenting site of cancer: Comparison with metastatic pleural effusions from known cancers;Pleurésies malignes révélatrices d'un cancer: Comparaison des étiologies avec les pleurésies métastatiques d'un cancer connu

Revue des Maladies Respiratoires

Volumn 25, Issue 9, 2008, Pages 1104-1109

  Cellerin, L ^a,b   Marcq, M ^a   Sagan, C ^a   Chailleux, E ^a  

^a CHU de Nantes   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Malignant pleural effusion; Primary cancer; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; CYTOPATHOLOGY; FEMALE; FRANCE; HUMAN; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT PLEURAL EFFUSION; MESOTHELIOMA; OVARY CARCINOMA; PATIENT SELECTION; PLEURA BIOPSY; PLEURA EFFUSION; PLEURA FLUID; PLEURA METASTASIS; SEX DIFFERENCE; SEX RATIO;

EID: 58149140221     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(08)74980-5     Document Type: Article

References (18)

1. American Thoracic Society : Management of malignant pleural effusions. Am J Respir Crit Care Med. 2000 ; 162 : 1987-2001.
2. Antunes G, Neville E, Duffy J, Ali N : BTS guidelines of management of malignant pleural effusion. Thorax 2003 ; 58 : ii29-38.
3. Monte SA, Ehya H, Lang WR : Positive effusion cytology as the initial presentation of malignancy. Acta Cytol 1987 ; 31 : 448-52.
4. Chernow B, Sahn SA : Carcinomatous involvement of the pleura. An analysis of 96 patients. Am J Med 1977 ; 63 : 695-702.
5. Johnston WW : The malignant pleural effusions. A review of cytopathologic diagnosis of 584 specimens from 472 consecutive patients. Cancer 1985 ; 56 : 905-9.
6. Valdes L, Alvarez D, Valle JM, Pose A, San Jose E : The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest 1996 ; 109 : 158-62.
7. Hsu C : Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients. Diagn Cytopathol 1987 ; 3 : 8-12.
8. Sahn SA : Pleural diseases related to metastatic malignancies. Eur Respir J 1997 ; 10 : 1907-13.
9. Rodriguez-panadero F, Bordenas Naranjo F, Lopez M : Pleural metastatic tumour and effusion. Frequency and pathogenic mechanisms in a post-mortem series. Eur Respir J 1989 ; 2 : 366-9.
10. Meyer PC : Metastatic carcinoma of the pleura. Thorax 1966 ; 21 ; 437-43.
11. Molinié F, Velten M, Remontet L, Bercelli P : le Réseau FRANCIM. Évolution de l'incidence du cancer bronchopulmonaire en France (1978-2000). Rev Mal Respir 2006 ; 23 : 127-34.
12. Peto J, Decarli A, La Vecchia C, Levi F, Negri E : The European mesothelioma epidemic. Br J Cancer 1999 ; 79 : 666-72.
13. Chailleux E, Pioche D, Chopra S, Dabouis G, Germaud P, De Lajartre AY, De Lajartre M : Epidemiology of malignant pleural mesothelioma in the Nantes-Saint Nazaire region. Course in 1956-1992. Rev Mal Respir 1995 ; 12 : 353-7.
14. Ang P,T AH, Leong SS, Koh L, Eng P, Agasthian T : Primary intrathoracic malignant effusion. Chest 2001 ; 120 : 50-4.
15. Lau SK, Luthringer MD, Eisen RN : TTF1: a review. Appl immunohistochem Molecular Morphol 2002 ; 97 : 97-102.
16. Sanchez-Armengol A, Rodriguez-panaderoF : Survival and talc pleurodesis in metastatic pleural carcinoma revisited. Chest 1993 ; 104 : 1482-5.
17. Van de Molengraft FJJM, Vooijs GP : Survival of patients with malignancy associated effusions. Acta Cytol 1989 ; 33 : 911-6.
18. Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K : Prognostic value of pleural effusion in patients with non small cell lung cancer. Clin Cancer Res 1997; 3 : 47-50.